Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.
An economist's harrowing escape from fire, and her big ideas to rescue California from its insurance doom spiral.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback